Review
Open access
Aug 2026
Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation
A broad overview of established multidisciplinary management of both limited-stage and extensive-stage SCLC is discussed to provide understanding of how the next decade is likely to bring significant clinical gains as emerging therapeutics seek to redefine the management of SCLC and build upon novel advances.
Shrey Sindhwani, Miles Thomas, Kanika Gehlaut et al.
· Drugs · 0 citations